Announcement of Resolutions from the 21st Meeting of the 11th Board of Directors

Dong-E-E-Jiao Co., Ltd.·May 26, 2026·2 pages

✨ AI Summary

The 21st meeting of the 11th Board of Directors of Dong'e Ejiao Co., Ltd. approved the acquisition of 80% equity in Shuzhong Pharmaceutical (Jilin) Co., Ltd. for approximately 208 million yuan. The company will invest 104 million yuan in cash for a 70% stake, while its partner will acquire the remaining 20%. This transaction will make Shuzhong Jilin a subsidiary and does not require shareholder approval.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Dong'e Ejiao Co., Ltd. (hereinafter referred to as "the Company" or "Dong'e Ejiao") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

I. Meeting Information

The 21st meeting of the 11th Board of Directors of Dong'e Ejiao Co., Ltd. was notified via email on May 23, 2026.
The meeting was held on May 26, 2026, through a communication voting method.
There were 9 directors required to attend, and all 9 directors were present.
The convening of this Board meeting complies with relevant laws, administrative regulations, departmental rules, normative documents, and the Company’s Articles of Association.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.